{"id":2492,"date":"2022-02-07T22:06:00","date_gmt":"2022-02-07T22:06:00","guid":{"rendered":"https:\/\/www.amalgamatedbenefits.com\/amalgamated-life\/?p=2492"},"modified":"2023-07-31T17:02:05","modified_gmt":"2023-07-31T21:02:05","slug":"limra-reports-double-digit-growth-in-workplace-life-disability-and-supplemental-health-products","status":"publish","type":"post","link":"https:\/\/www.amalgamatedbenefits.com\/amalgamated-life\/limra-reports-double-digit-growth-in-workplace-life-disability-and-supplemental-health-products\/","title":{"rendered":"LIMRA Reports Double-Digit Growth in Workplace Life, Disability and Supplemental Health Products"},"content":{"rendered":"
\"Colleagues<\/figure>\n

The third quarter of 2021 proved to be a phenomenal one for the sales of workplace life insurance, disability insurance and supplemental health products according to recent LIMRA research. In fact, products in several categories recorded double-digit growth. This is especially encouraging given how these products performed in 2020.<\/h2>\n

Patrick Leary, Corporate Vice President of LIMRA\u2019s Workplace Benefits Research Program, states, \u201cAfter the disappointing results in 2020, workplace benefit sales have rebounded in 2021. In a very competitive job market, employers recognize the need to offer a robust benefits package to attract and retain the best talent. Our research suggests non-medical benefits to rise at least 20% over the next five years.\u201d<\/p>\n

For those marketing and selling these products, there is a significant opportunity to capitalize on what is a clear demand for workplace benefits. LIMRA\u2019s figures make a strong case that these products should be highlighted in any benefits program and a strong focus for sales representatives and brokers.<\/p>\n

As for how the various products specifically performed in Q3 2021, LIMRA\u2019s research indicated:<\/p>\n